1. Infectious disease in an era of global change;Baker;Nat. Rev. Microbiol.,2022
2. Structural basis of SARS-COV-2 polymerase inhibition by favipiravir;Peng;Innovation,2021
3. Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID-19 patients: a prospective, multicenter, open-label, randomized controlled clinical trial;Chen;Front. Pharmacol.,2021
4. The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists. part ii: complex modifications to the nucleoside scaffold;Yates;Antiviral Res.,2019
5. SARS-COV-2 RNA dependent RNA polymerase (RDRP) targeting: An in silico perspective;Elfiky;J. Biomol. Struct. Dyn.,2021